| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/19/2006 | EP1680445A1 Polyvalent allergy vaccine |
| 07/19/2006 | EP1680443A2 Stabilized alpha helical peptides and uses thereof |
| 07/19/2006 | EP1680439A2 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 07/19/2006 | EP1680150A1 Composite material containing hydrogen, produced by the electrically-triggered precipitation of a solid phase |
| 07/19/2006 | EP1680148A1 Hydrogel-containing medical articles and methods of using and making the same |
| 07/19/2006 | EP1680139A2 Use of somatostatin or one of the analogs thereof for producing a medicament serving to regulate the ovarian follicular reserve in non-menopausal women |
| 07/19/2006 | EP1680138A1 Combination therapy |
| 07/19/2006 | EP1680137A2 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 07/19/2006 | EP1680136A1 Peptides having, for example, an antiangiogenic activity and applications thereof in therapeutics |
| 07/19/2006 | EP1680121A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 07/19/2006 | EP1680120A2 Combinations useful for the treatment of neuronal disorders |
| 07/19/2006 | EP1680118A1 Combination of a farnesyl transferase inhibitor with an antihormonal agent for the treatment of breast cancer |
| 07/19/2006 | EP1680114A2 Triazole compounds and uses related thereto |
| 07/19/2006 | EP1680080A2 Neutrophil activation by immune response modifier compounds |
| 07/19/2006 | EP1680009A2 Compositions and methods for diagnosing and treating mental disorders |
| 07/19/2006 | EP1623038A4 Process for manufacture of nematode-extracted anticoagulant protein (nap) |
| 07/19/2006 | EP1616183A4 Methods of detecting neurological disorders |
| 07/19/2006 | EP1492476B1 Device for mixing and/or injecting cements |
| 07/19/2006 | EP1483284B1 Selective dipeptide inhibitors of kallikrein |
| 07/19/2006 | EP1463812A4 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 07/19/2006 | EP1442058B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/19/2006 | EP1395273B1 Targeted delivery of drugs for the treatment of viral infections |
| 07/19/2006 | EP1389137B1 Compositions for protein delivery via the pulmonary route |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1289502B1 Microemulsion preconcentrates, microemulsion and use of such a composition |
| 07/19/2006 | EP1220684B1 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/19/2006 | EP1179588B9 Human brain carboxypeptidase b |
| 07/19/2006 | EP1082967B1 Prevention and treatment of autoimmune demyelinating diseases by Fas-antagonists |
| 07/19/2006 | EP1075492B1 Melanocortin 1 receptor selective compounds |
| 07/19/2006 | EP0988314B1 Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 07/19/2006 | EP0966481B1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 07/19/2006 | EP0898580B1 Methods and means for inhibition of cdk4 activity |
| 07/19/2006 | EP0835447B1 Novel peptides and compositions which modulate apoptosis |
| 07/19/2006 | CN1806041A Odor control compositions and methods |
| 07/19/2006 | CN1805759A Uptake of macromolecules |
| 07/19/2006 | CN1805758A Nucleotide and cellular vaccine composition |
| 07/19/2006 | CN1805756A Vav inhibition in graft rejection. |
| 07/19/2006 | CN1805753A Treatment of severe acute respiratory syndrome (SARS) |
| 07/19/2006 | CN1805752A Water-soluble shps as novel alkylating agents |
| 07/19/2006 | CN1805751A Methods of managing the symptoms of premenstrual syndrome. |
| 07/19/2006 | CN1805733A Absorption enhancers such as e.g. BHTíóBHA or propyl gallate |
| 07/19/2006 | CN1804039A Virulence genes, proteins, and their use |
| 07/19/2006 | CN1804037A Expression method of glucosal related protein and application thereof |
| 07/19/2006 | CN1804032A Novel earthworm fibrinolytic enzyme, its encoding sequence and uses |
| 07/19/2006 | CN1803838A Follicle stimulating hormone receptor(FSHR) specific binding region polypeptide, its expression vector, preparation method and application in drug preparation |
| 07/19/2006 | CN1803837A Neurotrophic growth factor |
| 07/19/2006 | CN1803835A Active polypeptide of brown-spotted torrential frog, its gene and application in drug preparation |
| 07/19/2006 | CN1803834A Antibacterial peptide of brown-spotted torrential frog, its gene and application in drug preparation |
| 07/19/2006 | CN1803833A Gene for inhibiting human transcription factor AP-1, its encoding polypeptide and uses |
| 07/19/2006 | CN1803832A 12-mer peptide, compound containing the same, its preparation method and application in cancer treatment drug |
| 07/19/2006 | CN1803830A Artificial synthesized insulin-simulated peptide and its application |
| 07/19/2006 | CN1803189A Use of botulinum toxin for the treatment of unstable bladder |
| 07/19/2006 | CN1264980C Novel tumor antigen protein SART-3 and tumor antigen peptide thereof |
| 07/19/2006 | CN1264862C Diphtherin-gonadoliberin chimeric protein |
| 07/19/2006 | CN1264861C Receptor targeting chimeric toxin with junctional sequence |
| 07/19/2006 | CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 07/19/2006 | CN1264857C Recombinant fusion protein (vaccine), composition containing the same and method for prodution thereof |
| 07/19/2006 | CN1264856C Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 07/19/2006 | CN1264833C Nonviscous protein type synthetic compound or its carrier combined compound |
| 07/19/2006 | CN1264578C Carrier with solid fibrinogen and solid thrombin |
| 07/19/2006 | CN1264575C PEG or polyethylene oxide-urate oxidase conjugates and use thereof |
| 07/19/2006 | CN1264570C Therapeutic use of growth factor VEGF in preparing medicine for preventing and treating endangium hyperplasia |
| 07/19/2006 | CN1264569C Protein-free preparations |
| 07/19/2006 | CN1264568C Virulence genes and proteins, and their use |
| 07/19/2006 | CN1264567C Garlic protein zymolysis serial product and its preparation method and use |
| 07/18/2006 | USRE39192 biocompatible wound healing agents comprising growth factors or drugs and fibrinogen |
| 07/18/2006 | US7078572 Preparing an aldehyde intermediates for anticancer drugs, by decyclization of a substituted oxiranes or reducing a nitrile with a reducing agent; free of hazard azide intermediate, no need of purification by column chromatography |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078513 plasmid is a viral or bacterial expression vector and is expressed in a prokaryotic or eukaryotic cell; gene therapy and immunotherapy; prenatal screening and diagnosis |
| 07/18/2006 | US7078512 Encoding feline CD-86, -80, -28 and -152 receptors and ligands; enhancing and suppressing immune response in felines |
| 07/18/2006 | US7078511 nucleic acid molecule encoding Hamster scavenger receptor BI (HaSR-BI) which has high affinity for low density lipoproteins (LDL) and acylated LDL, expressed in adipocytes; antilipemic, anticholesterol agents; receptor binding assay; drug screening |
| 07/18/2006 | US7078508 Anticoagulant; Dna immobilized on substrate; binding to antibody |
| 07/18/2006 | US7078506 Canineil-4nucleic acid molecules and uses thereof |
| 07/18/2006 | US7078494 Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding |
| 07/18/2006 | US7078490 Artificial antibody polypeptides |
| 07/18/2006 | US7078487 Polynucleotides encoding the zebrafish PTH1R (parthyroid hormone like protein) receptor |
| 07/18/2006 | US7078485 Endostatin proteins with metal chelate compounds with peptide sequences for treating angiogenesis diseases and reduction |
| 07/18/2006 | US7078482 An isolated protein of homology between the amino acid sequence ID NO: 1 and 2 and known amino acid sequences of other proteins such as human eosinophil granule major basic protein; anticarcinogenic0, -tumor and -inflammatory agents; leukemia; viricides; wound healing agents; parasiticides; immunology |
| 07/18/2006 | US7078480 Process for stabilizing the content of glycated protein of a sample on a matrix material |
| 07/18/2006 | US7078479 Factor VII or a factor VII-related polypeptide and alpha2-antiplasmin or an alpha2-antiplasmin-related polypeptide, and the use thereof for treating bleeding episodes. |
| 07/18/2006 | US7078478 Deletion mutations to inhibit binding of tyrosine kinase; interleukin receptor proteins; antiproliferative agent; antitumor agent |
| 07/18/2006 | US7078416 Polypeptides |
| 07/18/2006 | US7078413 Compositions and methods of use for a bombesin peptide |
| 07/18/2006 | US7078397 Comprises thiadiazolidinedione-based insulin sensitizers (troglitazone); peroxisome proliferator-activated receptors |
| 07/18/2006 | US7078385 For therapy of diseases or disorders involving abnormal angiogenesis |
| 07/18/2006 | US7078384 Mimetic insect allatostatin analogs for insect control |
| 07/18/2006 | US7078383 Genetic engineered protein; enzyme inhibitor; respiratory system disorders; genetic disorders |
| 07/18/2006 | US7078382 Modulation of eNOS activity and therapeutic uses thereof |
| 07/18/2006 | US7078381 Method of regulating glucose metabolism, and reagents related thereto |
| 07/18/2006 | US7078380 comprises vancomycin-type antibiotics; peptide antibiotics; membrane proteins; defensins; for inhibiting peptidoglycan biosynthesis |
| 07/18/2006 | US7078379 Treatment of congenital muscular dystrophies |
| 07/18/2006 | US7078378 Method of tissue repair II |
| 07/18/2006 | US7078377 Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains |
| 07/18/2006 | US7078376 blood disorders; analgesics; nausea; cardiovascular disorders; anticancer agents; hypotensive agents; headaches; edema; diarrhea; thrombosis; reducing dosage |
| 07/18/2006 | US7078236 Methods of inducing ovulation |
| 07/18/2006 | US7078221 Genetic engineered protein; bone disorders |
| 07/18/2006 | US7078206 for drug screening enzyme inhibitors; by isolating DNA from a patient, amplifying exons by polymerase chain reaction (PCR) and detecting the presence of DNA sequence variation; genetic engineering |
| 07/18/2006 | US7078205 Nucleotide sequences coding polypeptide for use in the treatment of schizophrenia and alzheimer's diseases |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078195 Useful as anti-bacterial agents |